Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,367 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dendritic/tumor fusion cell-based vaccination against cancer.
Koido S, Hara E, Homma S, Fujise K, Gong J, Tajiri H. Koido S, et al. Among authors: homma s. Arch Immunol Ther Exp (Warsz). 2007 Sep-Oct;55(5):281-7. doi: 10.1007/s00005-007-0034-6. Arch Immunol Ther Exp (Warsz). 2007. PMID: 18219758 Free article. Review.
Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines.
Koido S, Homma S, Takahara A, Namiki Y, Komita H, Nagasaki E, Ito M, Nagatsuma K, Uchiyama K, Satoh K, Ohkusa T, Gong J, Tajiri H. Koido S, et al. Among authors: homma s. J Biomed Biotechnol. 2011;2011:910836. doi: 10.1155/2011/910836. Epub 2011 Apr 26. J Biomed Biotechnol. 2011. PMID: 21541197 Free PMC article. Review.
Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer.
Koido S, Homma S, Okamoto M, Takakura K, Mori M, Yoshizaki S, Tsukinaga S, Odahara S, Koyama S, Imazu H, Uchiyama K, Kajihara M, Arakawa H, Misawa T, Toyama Y, Yanagisawa S, Ikegami M, Kan S, Hayashi K, Komita H, Kamata Y, Ito M, Ishidao T, Yusa S, Shimodaira S, Gong J, Sugiyama H, Ohkusa T, Tajiri H. Koido S, et al. Among authors: homma s. Clin Cancer Res. 2014 Aug 15;20(16):4228-39. doi: 10.1158/1078-0432.CCR-14-0314. Epub 2014 Jul 23. Clin Cancer Res. 2014. PMID: 25056373 Clinical Trial.
Prognostic markers for patient outcome following vaccination with multiple MHC Class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for pancreatic cancer.
Takakura K, Koido S, Kan S, Yoshida K, Mori M, Hirano Y, Ito Z, Kobayashi H, Takami S, Matsumoto Y, Kajihara M, Misawa T, Okamoto M, Sugiyama H, Homma S, Ohkusa T, Tajiri H. Takakura K, et al. Among authors: homma s. Anticancer Res. 2015 Jan;35(1):555-62. Anticancer Res. 2015. PMID: 25550602
Dendritic cell-based vaccine for pancreatic cancer in Japan.
Okamoto M, Kobayashi M, Yonemitsu Y, Koido S, Homma S. Okamoto M, et al. Among authors: homma s. World J Gastrointest Pharmacol Ther. 2016 Feb 6;7(1):133-8. doi: 10.4292/wjgpt.v7.i1.133. World J Gastrointest Pharmacol Ther. 2016. PMID: 26855819 Free PMC article. Review.
Cancer vaccine by fusions of dendritic and cancer cells.
Koido S, Hara E, Homma S, Namiki Y, Ohkusa T, Gong J, Tajiri H. Koido S, et al. Among authors: homma s. Clin Dev Immunol. 2009;2009:657369. doi: 10.1155/2009/657369. Epub 2010 Feb 18. Clin Dev Immunol. 2009. PMID: 20182533 Free PMC article. Review.
Dendritic/pancreatic carcinoma fusions for clinical use: Comparative functional analysis of healthy- versus patient-derived fusions.
Koido S, Hara E, Homma S, Namiki Y, Komita H, Takahara A, Nagasaki E, Ito M, Sagawa Y, Mitsunaga M, Uchiyama K, Satoh K, Arihiro S, Ohkusa T, Gong J, Tajiri H. Koido S, et al. Among authors: homma s. Clin Immunol. 2010 Jun;135(3):384-400. doi: 10.1016/j.clim.2010.02.003. Epub 2010 Mar 11. Clin Immunol. 2010. PMID: 20226739
1,367 results